These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1694908)

  • 21. Effects of intra-arterial ketanserin in Raynaud's phenomenon assessed by 99MTc-pertechnetate scintigraphy.
    Kunnen JJ; Dahler HP; Doorenspleet JG; van Oene JC
    Eur J Clin Pharmacol; 1988; 34(3):267-71. PubMed ID: 2840293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laser-Doppler measurement of digital blood flow regulation in normals and in patients with Raynaud's phenomenon.
    Kristensen JK; Engelhart M; Nielsen T
    Acta Derm Venereol; 1983; 63(1):43-7. PubMed ID: 6191488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonergic vasoconstriction in human fingers during reflex sympathetic response to cooling.
    Coffman JD; Cohen RA
    Am J Physiol; 1988 May; 254(5 Pt 2):H889-93. PubMed ID: 3364592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International study of ketanserin in Raynaud's phenomenon.
    Coffman JD; Clement DL; Creager MA; Dormandy JA; Janssens MM; McKendry RJ; Murray GD; Nielsen SL
    Am J Med; 1989 Sep; 87(3):264-8. PubMed ID: 2672807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon.
    Whitmore SE; Wigley FM; Wise RA
    J Rheumatol; 1995 Jan; 22(1):50-4. PubMed ID: 7699682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketanserin and capillary flow in Raynaud's phenomenon.
    Tooke JE; Williams SA; Rawlinson DW; Black C
    Int J Microcirc Clin Exp; 1990 Aug; 9(3):249-55. PubMed ID: 2394546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digital blood flow in cooled and contralateral finger in patients with Raynaud's phenomenon. Comparative measurements between photoelectrical plethysmography and laser Doppler flowmetry.
    Suichies HE; Aarnoudse JG; Wouda AA; Jentink HW; de Mul FF; Greve J
    Angiology; 1992 Feb; 43(2):134-41. PubMed ID: 1536474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketanserin in the treatment of Raynaud's phenomenon associated with generalized scleroderma.
    Engelhart M
    Br J Dermatol; 1988 Dec; 119(6):751-4. PubMed ID: 3060193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The blood supply to fingers during Raynaud's attack: a comparison of laser-Doppler flowmetry with other techniques.
    Engelhart M; Nielsen HV; Kristensen JK
    Clin Physiol; 1985 Oct; 5(5):447-53. PubMed ID: 3902334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New prospects for the treatment of Raynaud's phenomenon using a serotoninergic S2 receptor antagonist (ketanserin) and stable derivatives of prostacyclin.
    Pola P; Tondi P; Serricchio M; Favuzzi A; Gerardino L
    Angiology; 1993 Feb; 44(2):123-8. PubMed ID: 8434805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon.
    Codella O; Caramaschi P; Olivieri O; Perbellini L; Perbellini A; Bambara LM; Corrocher R; De Sandre G
    Angiology; 1989 Feb; 40(2):114-21. PubMed ID: 2644876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenon.
    Engelhart M; Seibold JR
    Angiology; 1990 Sep; 41(9 Pt 1):715-23. PubMed ID: 2221472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cold hands after exposure to arsenic or vibrating tools: effects of ketanserin on finger blood pressure and skin temperature.
    Lagerkvist BE; Linderholm H
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):327-32. PubMed ID: 2943135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative study of the effects of Ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled investigation and an additional long term open trial.
    van de Wal HJ; Wijn PF; van Lier HJ; Skotnicki SH
    Microcirc Endothelium Lymphatics; 1985; 2(6):657-85. PubMed ID: 2942753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin and Raynaud's phenomenon.
    Seibold JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S95-8. PubMed ID: 2412070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenoceptors in Raynaud's disease.
    Lindblad LE; Ekenvall L; Etzell BM; Bevegård S
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):881-5. PubMed ID: 2481777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raynaud's phenomenon. An update.
    Coffman JD
    Hypertension; 1991 May; 17(5):593-602. PubMed ID: 2022404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic efficacy of ketanserin, a selective antagonist of the serotonin (5-HT2) receptors, in primary and secondary Raynaud's phenomenon.
    Meloni F; Transi MG; Sciacca V; De Felice C; Bagarone A; Sciacca A
    Angiology; 1987 Jul; 38(7):530-6. PubMed ID: 3619126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular responses to histamine at low temperatures in normal digital skin and Raynaud's phenomenon.
    Bunker CB; Foreman JC; Dowd PM
    Agents Actions; 1991 May; 33(1-2):197-9. PubMed ID: 1716828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-adrenergic and serotonergic mechanisms in the human digit.
    Coffman JD; Cohen RA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S49-53. PubMed ID: 2459515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.